Citations

Showing 10 of 108094 citations.

The New Precision Stewards?
Meagher, Karen M. , Watson, Sara , Suh, Gina A. , Virk, Abinash , Meagher, Karen M , Suh, Gina A

Mayo Clinic

Journal of Personalized Medicine | August 15, 2022 | Volume: 12 | Issue: 8 | Pages: 1308

10.3390/jpm12081308 | PMID 36013256 Get It

The precision health era is likely to reduce and respond to antimicrobial resistance (AMR). Our stewardship and precision efforts share terminology, seeking to deliver the “right drug, at the right dose, at the right time.” Already, rapid diagnostic testing, phylogenetic surveillance, and real-time outbreak response provide just a few examples of molecular advances we dub “precision stewardship.” However, the AMR causal factors range from the molecular to that of global health policy. Mirroring the cross-sectoral nature of AMR science, the research addressing the ethical, legal and social implications (ELSI) of AMR ranges across academic scholarship. As the rise of AMR is accompanied by an escalating sense of its moral and social significance, what is needed is a parallel field of study. In this paper, we offer a gap analysis of this terrain, or an agenda for “the ELSI of precision stewardship.” In the first section, we discuss the accomplishments of a multi-decade U.S. national investment in ELSI research attending to the advances in human genetics. In the next section, we provide an overview of distinct ELSI topics pertinent to AMR. The distinctiveness of an ELSI agenda for precision stewardship suggests new opportunities for collaboration to build the stewardship teams of the future.
Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin
Piasecki, Thomas M. , Smith, Stevens S. , Baker, Timothy B. , Fiore, Michael C. , Adsit, Robert T. , Bolt, Daniel M. , Conner, Karen L. , Bernstein, Steven L. , Eng, Oliver S. , Lazuk, David , Gonzalez, Alec , Hayes-Birchler, Todd , Jorenby, Douglas E. , D’Angelo, Heather , Kirsch, Julie A. , Williams, Brian , Kent, Sean , Kim, Hanna , Lubanski, Stanley A. , Cai, Yuxin , Kashyap, Nitu , Mathew, Jomol , McMahan, Gabriel , Rolland, Betsy , Tindle, Hilary A. , Warren, Graham , Abu-el-rub, Noor , An, Lawrence C. , Boyd, Andrew D. , Brunzell, Darlene H., Carrillo, Victor A. , Chen, Li‐Shiun , Davis, James M. , Deshmukh, Vikrant , Dilip, Deepika , Ha, Patrick K. , Jose, Thulasee , Klass, Elizabeth , Lui, Michelle , Poon, Chester , Tong, Elisa K. , Wilson, Karen M. , Theobald, Wendy E. , Nolan, Margaret B , Piasecki, Thomas M , Smith, Stevens S , Baker, Timothy B , Fiore, Michael C , Adsit, Robert T , Bolt, Daniel M , Conner, Karen L , Bernstein, Steven L , Eng, Oliver , Lazuk, David , Gonzalez, Alec , Hayes-Birchler, Todd , Jorenby, Douglas E , D'Angelo, Heather , Kirsch, Julie A , Williams, Brian S , Kent, Sean , Kim, Hanna , Lubanski, Stanley A , Yu, Menggang , Suk, Youmi , Cai, Yuxin , Kashyap, Nitu , Mathew, Jomol , McMahan, Gabriel , Rolland, Betsy , Tindle, Hilary A , Warren, Graham W , Abu-El-Rub, Noor , An, Lawrence C , Boyd, Andrew D , Carrillo, Victor A , Chen, Li-Shiun , Davis, James M , Deshmukh, Vikrant G , Dilip, Deepika , Goldstein, Adam O , Ha, Patrick K , Iturrate, Eduardo , Jose, Thulasee , Khanna, Niharika , King, Andrea , Klass, Elizabeth , Lui, Michelle , Mermelstein, Robin J , Poon, Chester , Tong, Elisa , Wilson, Karen M , Theobald, Wendy E , Slutske, Wendy S , Nolan, Margaret , Yu, Menggang

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | August 15, 2022 | Volume: 32 | Issue: 1 | Pages: 12-21

10.1158/1055-9965.epi-22-0500 | PMID 35965473 Get It

Abstract Background: There is mixed evidence about the relations of current versus past cancer with severe COVID-19 outcomes and how they vary by patient and cancer characteristics. Methods: Electronic health record data of 104,590 adult hospitalized patients with COVID-19 were obtained from 21 United States health systems from February 2020 through September 2021. In-hospital mortality and ICU admission were predicted from current and past cancer diagnoses. Moderation by patient characteristics, vaccination status, cancer type, and year of the pandemic was examined. Results: 6.8% of the patients had current (n = 7,141) and 6.5% had past (n = 6,749) cancer diagnoses. Current cancer predicted both severe outcomes but past cancer did not; adjusted odds ratios (aOR) for mortality were 1.58 [95% confidence interval (CI), 1.46–1.70] and 1.04 (95% CI, 0.96–1.13), respectively. Mortality rates decreased over the pandemic but the incremental risk of current cancer persisted, with the increment being larger among younger vs. older patients. Prior COVID-19 vaccination reduced mortality generally and among those with current cancer (aOR, 0.69; 95% CI, 0.53–0.90). Conclusions: Current cancer, especially among younger patients, posed a substantially increased risk for death and ICU admission among patients with COVID-19; prior COVID-19 vaccination mitigated the risk associated with current cancer. Past history of cancer was not associated with higher risks for severe COVID-19 outcomes for most cancer types. Impact: This study clarifies the characteristics that modify the risk associated with cancer on severe COVID-19 outcomes across the first 20 months of the COVID-19 pandemic. See related commentary by Egan et al., p. 3
Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
Badve, Sunil , Cho, Sanghee , Cao, Sha , Ghose, Soumya , Thike, Aye Aye , Tan, Puay Hoon , Ocal, Idris Tolgay, Generali, Daniele , Harris, Adrian L. , Ginty, Fiona , Gökmen‐Polar, Yesim , Badve, Sunil S , Generali, Daniele , Harris, Adrian L , Gökmen-Polar, Yesim , Lu, Xiaoyu , Zanconati, Fabrizio

Mayo Clinic

Cancers | August 14, 2022 | Volume: 14 | Issue: 16 | Pages: 3916

10.3390/cancers14163916 | PMID 36010908 Get It

Tumor-infiltrating lymphocytes (TILs) are prognostic in invasive breast cancer. However, their prognostic significance in ductal carcinoma in situ (DCIS) has been controversial. To investigate the prognostic role of TILs in DCIS outcome, we used different scoring methods for TILs in multi-national cohorts from Asian and European women. Self-described race was genetically confirmed using QC Infinium array combined with radmixture software. Stromal TILs, touching TILs, circumferential TILs, and hotspots were quantified on H&E-stained slides and correlated with the development of second breast cancer events (BCE) and other clinico-pathological variables. In univariate survival analysis, age older than 50 years, hormone receptor positivity and the presence of circumferential TILs were weakly associated with the absence of BCE at the 5-year follow-up in all cohorts (p < 0.03; p < 0.02; and p < 0.02, respectively, adjusted p = 0.11). In the multivariable analysis, circumferential TILs were an independent predictor of a better outcome (Wald test p = 0.01), whereas younger age was associated with BCE. Asian patients were younger with larger, higher grade, HR negative DCIS lesions, and higher TIL variables. The spatial arrangement of TILs may serve as a better prognostic indicator in DCIS cases than stromal TILs alone and may be added in guidelines for TILs evaluation in DCIS.
Influenza infection is not associated with phenotypical frailty in older patients, a prospective cohort study
Takahashi, Paul Y. , Ryu, Euijung , Hickman, Joel , Pignolo, Robert J. , Juhn, Young J. , Takahashi, Paul , Pignolo, Robert, Juhn, Young, Wi, Chung‐Il , King, Katherine S.

Mayo Clinic

Health Science Reports | August 14, 2022 | Volume: 5 | Issue: 5 | Pages: No page available

10.1002/hsr2.750 | PMID 35989948 Get It

AbstractBackground and AimsInfluenza is a challenging infectious illness for older adults. It is not completely clear whether influenza is associated with frailty or functional decline. We sought to determine the association between incident influenza infection and frailty and prefrailty in community patients over 50 years of age. We also investigated the association between influenza vaccination and frailty and prefrailty as a secondary aim.MethodsThis was a prospective community cohort study from October 2019 to November 2020 in participants over 50 years. The primary outcome was the development of frailty as defined by three of five frailty criteria (slow gait speed, low grip strength, 5% weight loss, low energy, and low physical functioning). The primary predictor was a positive polymerase chain reaction (PCR) for influenza infection. Influenza vaccination was based on electronic health record reviewing 1 year before enrollment. We reported the relationship between influenza and frailty by calculating odds ratios (OR) with 95% confidence intervals (CI) after adjustment for age, sex, socioeconomic status, Charlson Comorbidity Index (CCI), influenza vaccine, and previous self‐rated frailty from multinomial logistic regression model comparing frail and prefrail to nonfrail subjects.ResultsIn 1135 participants, the median age was 67 years (interquartile range 60−74), with 41% men. Eighty‐one participants had PCR‐confirmed influenza (7.1%). Frailty was not associated with influenza, with an OR of 0.50 (95% CI 0.17−1.43) for frail participants compared to nonfrail participants. Influenza vaccination is associated with frailty, with an OR of 1.69 (95% CI 1.09−2.63) for frail compared to nonfrail. Frailty was associated with a higher CCI with an OR of 1.52 (95% CI 1.31−1.76).ConclusionWe did not find a relationship between influenza infection and frailty. We found higher vaccination rates in participants with frailty compared to nonfrail participants While influenza was not associated with frailty, future work may involve longer follow‐up.
NanoScope Arthroscopy: Lessons Learned in the First 75 Cases
Oh, Christine , Kakar, Sanjeev , Kakar, Sanjeev

Mayo Clinic

Journal of Wrist Surgery | August 13, 2022 | Volume: 11 | Issue: 04 | Pages: 280-287

10.1055/s-0042-1749089 | PMID 35971477 Get It

AbstractBackground The field of arthroscopy has exponentially grown in the past decade, especially in the realm of upper extremity surgery.Description The use of smaller cameras and further advancements in arthroscopy technology have allowed innovative expansion in the application of arthroscopy in small joints.Clinical Relevance Included in the advancements is the NanoScope, a 1.9-mm flexible scope specifically designed for small joint visualization.
The Elusive Surgeon Scientist: The Role of PhD in Careers of Cardiothoracic Surgeons
Stephens, Elizabeth H.

Mayo Clinic

World Journal of Surgery | August 13, 2022 | Volume: 46 | Issue: 10 | Pages: 2536-2537

10.1007/s00268-022-06699-3 | PMID 35963956 Get It

EFFECT OF PHYSICIAN FACE MASK USE ON POSTINJECTION ENDOPHTHALMITIS
Fortes, Blake H. , Astafurov, Konstantin , Hodge, David O. , Smith, Wendy M. , Olsen, Timothy W. , Iezzi, Raymond , Bakri, Sophie J. , Astafurov, Konstantin V, Barkmeier, Andrew J. , Fortes, Blake H

Mayo Clinic

Retina | August 13, 2022 | Volume: 42 | Issue: 11 | Pages: 2120-2127

10.1097/iae.0000000000003592 | PMID 35963006 Get It

Purpose: To examine the impact of physician face mask use on the rates and outcomes of postinjection endophthalmitis. Methods: A multicenter retrospective, comparative cohort study comparing endophthalmitis rate and visual acuity of eyes that developed endophthalmitis after antivascular endothelial growth factor injections at Mayo Clinic Rochester (MCR) and at Mayo Clinic Health System sites depending on physician masking. Results: A total of 164,824 injections were performed at MCR and Mayo Clinic Health System sites. Of these, 66,098 injections were in the no mask group and 98,726 injections were in the mask group. Overall, there were no differences in the rates of infectious endophthalmitis in the no mask versus mask cohorts (overall: no mask: 20 cases [0.0303%] vs. mask: 41 cases (0.0415%); P = 0.24; infectious: no mask: 12 cases [0.018%] versus mask: 13 cases [0.0132%]; P = 0.42). At MCR alone, there was a significant reduction in infectious endophthalmitis between the no mask versus mask groups (no mask: 9 cases [0.0297%] versus mask: 2 cases [0.003%]; P < 0.001). Only 2 cases of infectious endophthalmitis occurred at MCR after the face mask policy was implemented (1 in 30,000 injections). At presentation and at 6 months, the average visual acuity was similar for patients who developed endophthalmitis between the no mask versus mask groups. Conclusion: Physician face mask use did not affect the rate or outcome of postinjection endophthalmitis. However, there was a significant reduction at MCR after masking along with other quality improvement measures, including performance of injections in a dedicated procedure room and preparation of patients by nurses, that led to a low rate of endophthalmitis.
Response to Letter to the Editor From Banerjee and Mondal: “Management of Hyperglycemia in Hospitalized Adult Patients in Noncritical Care Settings: An Endocrine Society Clinical Practice Guideline”
Korytkowski, Mary T. , Muniyappa, Ranganath , Donihi, Amy C. , Drincic, Andjela , Hirsch, Irl B. , Murad, M. Hassan , Nielsen, Craig , Rushakoff, Robert J , Drincic, Angela , McDonnell, Marie E , Murad, M Hassan , Nielsen, Craig , Rushakoff, Robert J , Hirsch, Irl B , Muniyappa, Ranganath , McDonnell, Marie E.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | August 13, 2022 | Volume: 107 | Issue: 10 | Pages: e4276-e4277

10.1210/clinem/dgac479 | PMID 35962778 Get It

Cystic lesions of the retrorectal space
Brown, Ian , Sokolova, Anna , Rosty, Christophe , Brown, Ian S , Rosty, Christophe , Graham, Rondell P.

Mayo Clinic

Histopathology | August 13, 2022 | Volume: 82 | Issue: 2 | Pages: 232-241

10.1111/his.14769 | PMID 35962741 Get It

Cysts of the retrorectal space comprise a heterogeneous group of rare lesions. Most develop from embryological remnants and include tailgut cysts, dermoid cysts, rectal duplication cysts, anal canal duplication cysts, sacrococcygeal teratomas and anterior meningocoele. Tailgut cyst is the most common cyst of developmental origin, usually presenting as a multilocular cystic mass with mucoid content and lined by multiple epithelial types. Compared with tailgut cysts, rectal duplication cysts display all layers of the large bowel wall including a well‐defined muscularis propria. Retrorectal cysts of non‐developmental origin are far less common and represent lesions that either infrequently involve the retrorectal space or undergo extensive cystic change. This review provides an overview of the various histological types of cystic lesions of the retrorectal space, divided into cysts of developmental origin and those of non‐developmental origin. A practical pathological and multidisciplinary approach to diagnosing these lesions is presented.
Machine learning, pharmacogenomics, and clinical psychiatry: predicting antidepressant response in patients with major depressive disorder
Ommeren, Bailey Van, Athreya, Arjun P. , Bobo, William V. , Van Ommeren, Bailey

Mayo Clinic

Expert Review of Clinical Pharmacology | August 13, 2022 | Volume: 15 | Issue: 8 | Pages: 927-944

10.1080/17512433.2022.2112949 | PMID 35968639 Get It